An observational study in Cirrhosis, Sarcopenia and Malnutrition, sponsored by University of Sao Paulo. Completed at 1 site in Brazil. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-04-27.
Sponsored by University of Sao Paulo · Observational
The study evaluates whether sarcopenia influences the prevalence of abdominal hernias in patients with cirrhosis.
Sarcopenia is a common condition in patients with cirrhosis, with a prevalence of around 50%. It is unknown if the presence of sarcopenia may influence the prevalence of abdominal hernias in this group of patients. Clinical, nutritional and radiological evaluation will be performed in two groups of cirrhotic patients to evaluate this hypothesis.
Tertiary care adult patients with cirrhosis, with and without abdominal hernias.
Exclusion Criteria:
This group consists of cirrhotic patients with any abdominal hernia
Diagnostic Test: Computed Tomography Scan
This group consists of cirrhotic patients without any hernias
Diagnostic Test: Computed Tomography Scan
The results of the CT scan and the hand-grip test will be used for diagnosis of sarcopenia. The Royal Free Hospital-Global Assessment (RFH-GA) results will classify the nutritional status of the patient.
Also known as: Hand-grip test (dynamometer), Royal Free Hospital-Global Assessment
Prevalence of Sarcopenia
Prevalence of Sarcopenia in patients with cirrhosis
Time frame: Through study completion (an average of 1 year)
Influence of Sarcopenia in Prevalence of Abdominal Hernias in Patients with Cirrhosis
Influence of Sarcopenia in Prevalence of Abdominal Hernias in Patients with Cirrhosis
Time frame: Through study completion (an average of 1 year)
Plan to share: Undecided
This study is completed, as verified in Apr 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Sao Paulo